Anthrax News and Research

RSS
Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Anthrax most commonly occurs in wild and domestic lower vertebrates (cattle, sheep, goats, camels, antelopes, and other herbivores), but it can also occur in humans when they are exposed to infected animals or tissue from infected animals.

Anthrax is most common in agricultural regions where it occurs in animals. These include South and Central America, Southern and Eastern Europe, Asia, Africa, the Caribbean, and the Middle East. When anthrax affects humans, it is usually due to an occupational exposure to infected animals or their products. Workers who are exposed to dead animals and animal products from other countries where anthrax is more common may become infected with B. anthracis (industrial anthrax). Anthrax outbreaks occur in the United States on an annual basis in livestock and wild game animals such as deer.

Anthrax infection can occur in three forms: cutaneous (skin), inhalation, and gastrointestinal. B. anthracis spores can live in the soil for many years, and humans can become infected with anthrax by handling products from infected animals or by inhaling anthrax spores from contaminated animal products. Anthrax can also be spread by eating undercooked meat from infected animals. It is rare to find infected animals in the United States.
Online education program improved physicians' knowledge about the diagnosis and management of diseases caused by bioterrorism

Online education program improved physicians' knowledge about the diagnosis and management of diseases caused by bioterrorism

Vaccine candidate? Researchers synthesize oligosaccharide from anthrax pathogen

Vaccine candidate? Researchers synthesize oligosaccharide from anthrax pathogen

Antibiotic resistance has put humans in an escalating 'arms race' with infectious bacteria

Antibiotic resistance has put humans in an escalating 'arms race' with infectious bacteria

Researchers uncover how the inhaled form of anthrax disarms bacteria-fighting white blood cells before they can fend off the disease

Researchers uncover how the inhaled form of anthrax disarms bacteria-fighting white blood cells before they can fend off the disease

Shot in the arm for vaccines

Shot in the arm for vaccines

Designer molecules that combine metals such as copper with natural organic materials could treat diseases in the body

Designer molecules that combine metals such as copper with natural organic materials could treat diseases in the body

Anthrax test receives FDA approval

Anthrax test receives FDA approval

New laboratory method for quickly detecting active anthrax proteins

New laboratory method for quickly detecting active anthrax proteins

China battles with Anthrax as well as Swine flu

China battles with Anthrax as well as Swine flu

Florida federal health agency worker charged with anthrax hoax

Florida federal health agency worker charged with anthrax hoax

Pseudomonas aeruginosa has broken the immune system's code

Pseudomonas aeruginosa has broken the immune system's code

Key step in the entry of anthrax toxin into human cells

Key step in the entry of anthrax toxin into human cells

U.S. stockpile of anti-flu drugs is "totally inadequate"

U.S. stockpile of anti-flu drugs is "totally inadequate"

Results demonstrate the safety and tolerability of ABthrax treatment for Anthrax infection

Results demonstrate the safety and tolerability of ABthrax treatment for Anthrax infection

Blood pressure enzyme linked to SARS virus, could help fight diseases that cause lung failure

Blood pressure enzyme linked to SARS virus, could help fight diseases that cause lung failure

Product claiming to protect against anthrax lacks credentials or approval

Product claiming to protect against anthrax lacks credentials or approval

Scientists identify inhibitors of the anthrax toxin

Scientists identify inhibitors of the anthrax toxin

Brazil patent seizure threatens global trade and public health

Brazil patent seizure threatens global trade and public health

New technology developed at Cornell University could make it just as easy to identify genes

New technology developed at Cornell University could make it just as easy to identify genes

NIAID has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against bioterrorism

NIAID has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against bioterrorism